I think a2 have had difficulties in getting US fda approval because of the lobbying of the big 4 local formula manufacturers. They would be a much bigger threat to permanent market share than these smaller operators like bubs and care a2. Let’s see how this plays out as I think Bubs and care will end up being disapppointed.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$7.93 |
Change
0.000(0.00%) |
Mkt cap ! $5.741B | |||
| Open | High | Low | Value | Volume |
| $7.94 | $7.97 | $7.88 | $3.237M | 408.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 10105 | $7.92 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.94 | 45483 | 30 |
View Market Depth
| Last trade - 12.48pm 30/06/2025 (20 minute delay) ? |
| A2M (ASX) Chart |